Component-resolved allergy testing (Component-resolved diagnostics (molecular allergology))
A more detailed blood test that measures antibodies to individual proteins within an allergen, used by specialists to refine an allergy diagnosis and judge risk when simpler tests are unclear.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- It measures antibodies to individual proteins within an allergen, giving a more detailed picture than a standard allergy blood test.
- It is most useful for refining risk and telling a genuine allergy apart from a milder cross-reaction, not as a routine first test.
- Like all allergy tests it shows sensitisation and must be read alongside your symptoms by a specialist; cut-offs vary, so it guides rather than dictates.
- It does not prove allergy on its own and cannot exactly predict how severe a future reaction would be — a supervised challenge is sometimes still needed.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Can distinguish a genuine, potentially more serious allergy from a milder cross-reaction.
It is not a routine first-line test and should not be used to screen broadly without a clear question.
A quick blood sample from a vein, like any routine blood test.
Specialist interpretation of the pattern tied to your symptoms, not just a results sheet.
A quick blood sample from a vein, like any routine blood test.
You can carry on as normal; press on the site if there is any bruising.
The specialist laboratory reports the antibody levels to each component tested.
An allergy specialist explains the pattern, the likely risk, and what it means for you alongside your symptoms.

What is component-resolved allergy testing?
Allergens such as peanut or pollen are made up of many different proteins, called components. A standard allergy blood test measures antibodies to the whole allergen. Component-resolved diagnostics goes a step further and measures antibodies to the individual proteins inside it — for example, in peanut, proteins such as Ara h 2.
This extra detail can help in specific situations: distinguishing a genuine, potentially more serious allergy from a milder cross-reaction (such as a pollen-related response that only causes mild mouth itching), or refining the risk picture when simpler tests and the history do not agree. It is a specialist tool, usually added when it will actually change management, not a routine first test.
It is still a blood test that shows sensitisation, so the same rule applies: it must be interpreted alongside your symptoms by someone experienced. The protein patterns can suggest higher or lower risk, but cut-off levels vary between laboratories, ages and populations, so the result guides rather than dictates decisions, and it does not on its own prove allergy or predict exactly how severe a reaction would be.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
Standard IgE test versus component-resolved testing
| Feature | Standard specific IgE | Component-resolved test |
|---|---|---|
| Measures | Whole allergen | Individual proteins |
| Detail | Less | More |
| Main use | First-line testing | Refining risk, cross-reactivity |
| Interpretation | Specialist or GP | Specialist |
| Shows | Sensitisation | Sensitisation pattern |
Component testing usually builds on a standard test rather than replacing it, and adds most value when the simpler result and the history do not fit together.
Preparing for your test
- Have a clear account of your symptoms and suspected triggers; component testing is chosen to answer a specific question.
- You do not need to stop antihistamines for this blood test.
- Bring results of any previous allergy tests, as component testing often builds on them.
- Continue your usual medicines unless told otherwise.
- Be ready for the results to need careful specialist explanation rather than a simple yes or no.
- For children, plan for a blood sample and bring comfort items.
What happens
A small blood sample is taken from a vein, as for any blood test, and sent to a specialist laboratory. There it is tested for antibodies to specific allergen proteins, either one at a time or many together.
Results take days to a couple of weeks. A specialist then interprets the pattern: which proteins you react to, whether these are linked to higher or lower risk, and whether a positive result is a true allergy or a cross-reaction. This is more nuanced than a standard test and needs experience.
You should be told what the pattern means for you, how it changes (or does not change) the advice on avoidance and emergency treatment, and whether a supervised challenge would add certainty.
Is this test right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- It is not a routine first-line test and should not be used to screen broadly without a clear question.
- It cannot detect non-IgE (delayed) food reactions.
- It is not a substitute for a supervised challenge when a definite answer about tolerance is needed.
- It adds little when a standard test and the history already give a clear answer.
Delay or rearrange if…
- There is no clear clinical question that the test would answer.
- You are in the middle of an acute reaction needing treatment first.
- Earlier results are already sufficient and unchanged.
- Testing is being driven by anxiety rather than a specific decision — discuss with a specialist first.
Alternatives to discuss
- Standard specific IgE testing where that is sufficient.
- Skin prick testing for a quick same-day result.
- A supervised oral food challenge as the definitive test.
- Careful history and avoidance advice where the picture is already clear.
- No further testing if it would not change management.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Can distinguish a genuine, potentially more serious allergy from a milder cross-reaction.
- Helps refine risk when simpler tests and the history do not agree.
- Can reduce unnecessary avoidance where the pattern points to low risk.
- May help decide whether a supervised challenge is sensible.
- Uses a single blood sample and is not affected by antihistamines.
- Can support decisions about treatments such as immunotherapy in selected cases.
Risks & complications
- Minor bruising or discomfort where blood is taken.
- Complex results that are easy to misread without specialist help.
- Picking up sensitisation to proteins that has no clinical importance for you.
- A sense of false reassurance or false alarm if the pattern is over-interpreted.
- Results that still do not give a definite answer, needing a supervised challenge.
- Inconsistent or borderline patterns that are hard to act on.
- Cut-off values differing between laboratories, making comparison difficult.
- Feeling faint during the blood draw.
- A small localised infection or significant bruising at the needle site.
The main risk is misinterpretation. Component testing produces detailed information that can mislead if read without expertise, and cut-off levels vary between laboratories, ages and populations. It does not prove allergy or predict severity on its own. Ask for the result to be explained by an allergy specialist and for it to be tied back to your actual symptoms before any change to avoidance or treatment.
Published figures to discuss
Component testing detects sensitisation to individual proteins, and certain proteins are associated with higher or lower clinical risk — for peanut, for example, sensitisation to seed-storage proteins such as Ara h 2 tends to carry more risk than pollen-related cross-reactive proteins. However, cut-off levels that predict allergy or tolerance vary between study populations, age groups and regions, so reliable single percentages cannot be quoted, and results must be interpreted with the clinical history rather than used as fixed thresholds.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Component positivity without clinical allergy | Possible and sometimes common, depending on the component and background sensitisation | Components refine risk; they do not replace the clinical history. | Benefits and limitations of molecular diagnostics in peanut allergy (PMC)pmc.ncbi.nlm.nih.govSource-linked context |
| Ara h 2 positivity in peanut assessment | More predictive of true peanut allergy than whole-peanut IgE in many studies | A high-risk component can reduce uncertainty, but borderline results may still need challenge discussion. | Benefits and limitations of molecular diagnostics in peanut allergy (PMC)pmc.ncbi.nlm.nih.govSource-linked context |
| Pollen-food syndrome from cross-reactive components | Common in pollen-sensitised people | Mouth itching to raw fruit or nuts can have a different risk profile from storage-protein allergy. | Benefits and limitations of molecular diagnostics in peanut allergy (PMC)pmc.ncbi.nlm.nih.govSource-linked context |
| Unnecessary avoidance after over-interpreting components | A recognised risk | Results should be turned into a practical plan: avoid, eat normally, challenge, or carry adrenaline depending on history and risk. | Benefits and limitations of molecular diagnostics in peanut allergy (PMC)pmc.ncbi.nlm.nih.govSource-linked context |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no physical recovery. Afterwards, what matters is having the pattern of results explained by a specialist and understanding how it changes, or does not change, the advice on avoidance and emergency treatment.
- Slight bruising or tenderness at the needle site for a day or two.
- Waiting days to a couple of weeks for results.
- Finding the results need detailed explanation rather than a simple answer.
- Learning that some positive components do not matter for you.
- Being offered a supervised challenge if certainty is needed.
Aftercare
- Wait for an allergy specialist to interpret the pattern before changing your diet or routine.
- Do not relax or tighten avoidance on the basis of the test alone without specialist advice.
- Continue any prescribed emergency treatment, such as an adrenaline auto-injector, unless told otherwise.
- Ask how the pattern changes your individual risk and plan.
- Discuss whether a supervised challenge would add useful certainty.
- Make sure your GP has the results and any updated plan.
- Seek urgent help for any severe reaction while awaiting results.
- A clear account of your symptoms and suspected triggers
- Results of previous allergy tests to build on
- List of your current medicines
- Questions about how the pattern changes your risk and plan
- Comfort items for a child having blood taken
- Your GP's details so results can be shared
- A note not to change avoidance until results are explained
⚠ Get urgent help if…
- These warning signs relate to an allergic reaction, not the blood test itself.
- Difficulty breathing, wheeze, or a tight or swollen throat after a suspected trigger.
- Swelling of the lips, tongue or face.
- Feeling faint, dizzy or collapsing during a reaction.
- A widespread rash or hives with any breathing or swallowing difficulty.
- Any reaction worse or faster than before — use an adrenaline auto-injector if prescribed and call 999.
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A helpful result is a pattern that fits your history and refines your risk — for example pointing towards a genuine peanut allergy rather than a mild pollen cross-reaction, or the reverse. This can sharpen avoidance advice and decisions about emergency treatment or a challenge.
The test cannot prove allergy on its own, cannot exactly predict how severe a reaction would be, and uses cut-offs that vary between settings. Sometimes it narrows the question without fully answering it, and a supervised challenge remains the most definitive step.
As with other allergy tests, the result reflects your immune state at the time. Sensitisation patterns can change, especially in children. Repeat or further testing should be guided by a clinical question rather than done routinely, and significant decisions are best reviewed as symptoms evolve.
Related tests, treatments or support
Component-resolved testing is usually combined with the history, skin prick testing and standard specific IgE results, and may be followed by a supervised oral food challenge for a definite answer. It is one part of a specialist allergy assessment rather than a standalone diagnosis.
Follow-up & long-term care
Follow-up depends on the findings. A clear pattern that fits your history may complete the assessment with a specialist letter to your GP. An unclear pattern may lead to a supervised challenge, then review to confirm the diagnosis and agree avoidance and emergency plans.
- Further testing only when there is a clear clinical question.
- Reviewing risk and plans as symptoms change, especially in children.
- Keeping confirmed allergies and any emergency plan recorded with your GP.
- Reassessing if immunotherapy or other treatment is being considered.
Repeat, follow-on and what comes next
- An unclear pattern often needs a supervised challenge to resolve.
- Patterns can change over time, particularly in children.
- Decisions based on component testing may be revisited as symptoms evolve.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- Specialist interpretation of the pattern tied to your symptoms, not just a results sheet.
- Clear advice on whether avoidance or emergency treatment changes.
- A documented plan, including any adrenaline auto-injector, where relevant.
- Results and plan shared with your GP.
- A clear route to a supervised challenge if certainty is needed.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- How many components are tested, and whether a multiplex panel is used.
- The specialist laboratory used and turnaround time.
- Whether a specialist consultation to interpret the pattern is included.
- Whether it builds on existing tests or repeats them.
- Whether a supervised challenge follows to confirm the diagnosis.
- The complexity of the case and the seniority of the interpreting specialist.
- The cost per component or for a multiplex panel.
- Whether specialist interpretation is included.
- Who reports and explains the pattern of results.
- Whether a letter to your GP is provided.
- What further tests, such as a challenge, might be needed.
- What happens if the result remains inconclusive.
- The cancellation policy.
On the NHS? Component-resolved testing is available within NHS specialist allergy and immunology services when it will change management; it is also offered privately but is a specialist tool, not a routine screen.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Treating a component result as proof of allergy or tolerance without the history.
- Applying a cut-off from one population or laboratory as if it were universal.
- Over-relaxing or over-tightening avoidance on the test alone.
- Ordering broad multiplex testing without a clear clinical question.
- Not explaining the limits of what the pattern can predict about severity.
Marketing red flags
- Selling broad 'molecular allergy profiles' direct to consumers without a history.
- Promising precise risk or severity prediction from the test.
- Implying it can replace a supervised challenge.
- Encouraging changes to avoidance based on the printout alone.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- What specific question will this component test answer for me?
- How will the pattern change my avoidance or emergency plan?
- Could a positive component be a harmless cross-reaction rather than a true allergy?
- Does this make a supervised challenge more or less necessary?
- How do you account for different laboratory cut-offs when interpreting my result?
- How will the result be explained to me and shared with my GP?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my test, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this test not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
How is this different from a normal allergy blood test?
Do I need this test?
Will it tell me how severe my allergy is?
Does a positive component mean I am allergic?
Do I need to stop antihistamines?
Why do I need a specialist to read it?
Find a verified specialist for component-resolved allergy testing
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: EAACI Molecular Allergology User's Guide 2.0 (Wiley) Benefits and limitations of molecular diagnostics in peanut allergy (PMC) Using component-resolved diagnostics in peanut-allergic patients (PMC) Allergy UK — Food allergy testing and diagnosing Anaphylaxis UK — Allergy testing NICE CG116 — Food allergy in under 19s: assessment and diagnosis (2011) BSACI guideline — diagnosis and management of peanut and tree nut allergy (Stiefel et al., 2017) BSACI guideline — diagnosis and management of pollen food syndrome in the UK (Skypala et al., 2022)
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Allergy consultation · Specific IgE blood tests · Intradermal allergy testing · Oral food challenge · Drug allergy testing and challenge